Myomo
Update in progressMYO (NYSE American)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Myomo, Inc. develops and manufactures myoelectric orthotics and related software for people with neuromuscular disorders in the United States and globally. Its main product, the MyoPro upper-limb brace, assists weak or paralyzed arms to perform daily activities. Variants include MyoPro 2 (enhanced control software and removable battery), MyoPro 2+ (3D‑printed customization), and MyoGames, plus services such as MyoCare, MyoPal, and MyoCoach. Based in Burlington, MA, founded 2004.
Company score
- Sentiment
- 0.15
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.21
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.08
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.12
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE American (ASE)
- LocationUnited States
- CEOMr. Paul R. Gudonis
- Founded2004
- Employees194
- Websitemyomo.com
Identifiers
- ISINUS62857J2015
- FIGIBBG002B0JJV6
- LEI549300G63SSKC2EGLN41
- CUSIP62857J102
- CIK0001369290